Mediplantex National Pharmaceutical Joint Stock Company reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 97,355.3 million compared to VND 97,865.19 million a year ago. Net income was VND 3,424.32 million compared to VND 745.42 million a year ago. Basic earnings per share from continuing operations was VND 276 compared to VND 119 a year ago.
For the six months, revenue was VND 175,950.57 million compared to VND 197,548.17 million a year ago. Net loss was VND 1,573.49 million compared to net income of VND 4,759.82 million a year ago. Basic loss per share from continuing operations was VND 127 compared to basic earnings per share from continuing operations of VND 758 a year ago.